Success Metrics

Clinical Success Rate
40.0%

Based on 2 completed trials

Completion Rate
40%(2/5)
Active Trials
2(22%)
Results Posted
200%(4 trials)
Terminated
3(33%)

Phase Distribution

Ph not_applicable
1
11%
Ph phase_4
1
11%
Ph phase_1
2
22%
Ph phase_2
2
22%
Ph phase_3
2
22%

Phase Distribution

2

Early Stage

2

Mid Stage

3

Late Stage

Phase Distribution8 total trials
Phase 1Safety & dosage
2(25.0%)
Phase 2Efficacy & side effects
2(25.0%)
Phase 3Large-scale testing
2(25.0%)
Phase 4Post-market surveillance
1(12.5%)
N/ANon-phased studies
1(12.5%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

28.6%

2 of 7 finished

Non-Completion Rate

71.4%

5 ended early

Currently Active

2

trials recruiting

Total Trials

9

all time

Status Distribution
Active(2)
Completed(2)
Terminated(5)

Detailed Status

Terminated3
Withdrawn2
Completed2
Active, not recruiting1
Recruiting1

Development Timeline

Analytics

Development Status

Total Trials
9
Active
2
Success Rate
40.0%
Most Advanced
Phase 4

Trials by Phase

Phase 12 (25.0%)
Phase 22 (25.0%)
Phase 32 (25.0%)
Phase 41 (12.5%)
N/A1 (12.5%)

Trials by Status

terminated333%
withdrawn222%
active_not_recruiting111%
recruiting111%
completed222%

Recent Activity

2 active trials
Showing 5 of 9
terminatedphase_2

Durvalumab and Stereotactic Radiotherapy for Advanced NSCLC

NCT04786093
active_not_recruitingphase_3

Post-Surgical Stereotactic Radiotherapy (SRT) Versus GammaTile-ROADS (Radiation One and Done Study)

NCT04365374
recruitingphase_1

Trial of Anti-PD-1 Immunotherapy and Stereotactic Radiation in Patients With Recurrent Glioblastoma

NCT04977375
withdrawnphase_4

Post-operative Adjuvant Therapy w/wo GammaTile + Systemic Therapy

NCT05900908
withdrawnphase_2

Durvalumab (MEDI4736) and Radiosurgery (fSRT Vs. PULSAR) for the Treatment of Non-Small Cell Lung Cancer Brain Metastases

NCT04889066
View all 9 trials

Clinical Trials (9)

Showing 9 of 9 trials
NCT04786093Phase 2

Durvalumab and Stereotactic Radiotherapy for Advanced NSCLC

Terminated
NCT04365374Phase 3

Post-Surgical Stereotactic Radiotherapy (SRT) Versus GammaTile-ROADS (Radiation One and Done Study)

Active Not Recruiting
NCT04977375Phase 1

Trial of Anti-PD-1 Immunotherapy and Stereotactic Radiation in Patients With Recurrent Glioblastoma

Recruiting
NCT05900908Phase 4

Post-operative Adjuvant Therapy w/wo GammaTile + Systemic Therapy

Withdrawn
NCT04889066Phase 2

Durvalumab (MEDI4736) and Radiosurgery (fSRT Vs. PULSAR) for the Treatment of Non-Small Cell Lung Cancer Brain Metastases

Withdrawn
NCT01129687

Subtotal Resection of Large Acoustic Neuromas With Possible Stereotactic Radiation Therapy

Completed
NCT01527292Not Applicable

Phase II Trial of Stereotactic Radiation Therapy (SRT) Versus SRT Plus Vertebral Augmentation Procedure (VAP) for Vertebral Metastasis

Terminated
NCT00328510Phase 3

Comparing Two Forms of Head Immobilization for Stereotactic Radiotherapy

Completed
NCT00938457Phase 1

Stereotactic Radiation Therapy in Treating Patients With Liver Metastases

Terminated

All 9 trials loaded

Drug Details

Intervention Type
RADIATION
Total Trials
9